The goal of this program is to support the advancement of regulatory science that can (1) facilitate the implementation and the assessment of emerging manufacturing technology in the pharmaceutical sector; (2) expand the knowledge base related to complex products and formulation development, analysis, and manufacturing control to advance risk-based quality assessment of new and generic drug products.
Deadlines:
- Letter of Intent Due Date(s): February 28, 2020 for April 10, 2020 application due date. For all subsequent application due dates, letter of intent will be due 60 days prior to the application due date.
- Application Due Date(s)
April 10, 2020, by 11:59 PM Eastern Time.
April 5, 2021, by 11:59 PM Eastern Time.
April 4, 2022, by 11:59 PM Eastern Time.
PAR-20-083 Expiration Date April 11, 2022
Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect):
YR 01: $1,000,000
YR 02: $1,000,000
YR 03: $1,000,000
YR 04: $1,000,000
YR 05: $1,000,000